Cetuximab induces mitochondrial translocalization of EGFRvIII, but not EGFR: Involvement of mitochondria in tumor drug resistance?

Tumor Biology

Volumn 33, Issue 1, 2012, Pages 85-94

  Dreier, Agnieszka ^a   Barth, Stefan ^a   Goswami, Anand ^a   Weis, Joachim ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Cetuximab; EGFR; EGFRvIII; Mitochondria; Tumor drug resistance

Indexed keywords

CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 3; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B;

ANIMAL CELL; ARTICLE; CANCER RESISTANCE; CELL ACTIVITY; CELL FUNCTION; CELL PROLIFERATION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG PROTEIN BINDING; INTRACELLULAR SIGNALING; MITOCHONDRIAL TARGETING SIGNAL; MOLECULARLY TARGETED THERAPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION;

EID: 83655167238     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-011-0248-4     Document Type: Article

References (47)

1. A Wells 1999 EGF receptor Int J Biochem Cell Biol 31 6 637 643 10404636 10.1016/S1357-2725(99)00015-1 1:CAS:528:DyaK1MXkt1CjsrY%3D (Pubitemid 29248872)
2. RC Harris E Chung RJ Coffey 2003 EGF receptor ligands Exp Cell Res 284 1 2 13 12648462 10.1016/S0014-4827(02)00105-2 1:CAS:528:DC%2BD3sXitVylsbc%3D (Pubitemid 36331964)
3. AB Singh RC Harris 2005 Autocrine, paracrine and juxtacrine signaling by EGFR ligands Cell Signal 17 10 1183 1193 10.1016/j.cellsig.2005.03.026 15982853 10.1016/j.cellsig.2005.03.026 1:CAS:528:DC%2BD2MXmsVOns70%3D (Pubitemid 40984037)
4. N Prenzel OM Fischer S Streit S Hart A Ullrich 2001 The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification Endocr Relat Cancer 8 1 11 31 11350724 10.1677/erc.0.0080011 1:CAS:528:DC%2BD3MXkvFegurg%3D (Pubitemid 32520251)
5. EC Brantley EN Benveniste 2008 Signal transducer and activator of transcription-3: a molecular hub for signaling pathways in gliomas Mol Cancer Res 6 5 675 684 10.1158/1541-7786.MCR-07-2180 18505913 10.1158/1541-7786.MCR-07- 2180 1:CAS:528:DC%2BD1cXmt1Ojs7s%3D
6. MW Pedersen M Meltorn L Damstrup HS Poulsen 2001 The type III epidermal growth factor receptor mutation. Biological significance and potential target for anti-cancer therapy Ann Oncol 12 6 745 760 11484948 10.1023/A:1011177318162 1:STN:280:DC%2BD38%2FislSktw%3D%3D (Pubitemid 32655082)
7. PA Humphrey AJ Wong B Vogelstein MR Zalutsky GN Fuller GE Archer HS Friedman MM Kwatra SH Bigner DD Bigner 1990 Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma Proc Natl Acad Sci U S A 87 11 4207 4211 1693434 10.1073/pnas.87.11.4207 1:CAS:528:DyaK3cXltFensb0%3D (Pubitemid 20218011)
8. N Sugawa AJ Ekstrand CD James VP Collins 1990 Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas Proc Natl Acad Sci U S A 87 21 8602 8606 2236070 10.1073/pnas.87.21.8602 1:CAS:528:DyaK3MXhvVKntQ%3D%3D
9. SH Bigner PA Humphrey AJ Wong B Vogelstein J Mark HS Friedman DD Bigner 1990 Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts Cancer Res 50 24 8017 8022 2253244 1:CAS:528:DyaK3MXls1ejuw%3D%3D
10. H Yamazaki Y Ohba N Tamaoki M Shibuya 1990 A deletion mutation within the ligand binding domain is responsible for activation of epidermal growth factor receptor gene in human brain tumors Jpn J Cancer Res 81 8 773 779 2168866 10.1111/j.1349-7006.1990.tb02644.x 1:CAS:528:DyaK3cXlvVGrtr4%3D (Pubitemid 20246925)
11. M Nagane F Coufal H Lin O Bogler WK Cavenee HJ Huang 1996 A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis Cancer Res 56 21 5079 5086 8895767 1:CAS:528:DyaK28XmsFygtLs%3D (Pubitemid 26374452)
12. K Imai A Takaoka 2006 Comparing antibody and small-molecule therapies for cancer Nat Rev Cancer 6 9 714 727 10.1038/nrc1913 16929325 10.1038/nrc1913 1:CAS:528:DC%2BD28XosVOmsLo%3D (Pubitemid 44286003)
13. D Veale N Kerr GJ Gibson PJ Kelly AL Harris 1993 The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survival Br J Cancer 68 1 162 165 8391303 10.1038/bjc.1993.306 1:STN:280:DyaK3szgsFGnug%3D%3D (Pubitemid 23178571)
14. TA Libermann N Razon AD Bartal Y Yarden J Schlessinger H Soreq 1984 Expression of epidermal growth factor receptors in human brain tumors Cancer Res 44 2 753 760 6318976 1:CAS:528:DyaL2cXotlGqsA%3D%3D (Pubitemid 14184614)
15. FJ Hendler BW Ozanne 1984 Human squamous cell lung cancers express increased epidermal growth factor receptors J Clin Invest 74 2 647 651 10.1172/JCI111463 6086719 10.1172/JCI111463 1:CAS:528:DyaL2cXltVyhurg%3D (Pubitemid 14054014)
16. DE Neal C Marsh MK Bennett PD Abel RR Hall JR Sainsbury AL Harris 1985 Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours Lancet 1 8425 366 368 2857420 10.1016/S0140-6736(85)91386-8 1:STN:280:DyaL2M7htVSqtQ%3D%3D (Pubitemid 15163478)
17. DK Moscatello M Holgado-Madruga AK Godwin G Ramirez G Gunn PW Zoltick JA Biegel RL Hayes AJ Wong 1995 Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors Cancer Res 55 23 5536 5539 7585629 1:CAS:528:DyaK2MXps1KrtLw%3D
18. BR Voldborg L Damstrup M Spang-Thomsen HS Poulsen 1997 Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials Ann Oncol 8 12 1197 1206 9496384 10.1023/A:1008209720526 1:STN:280:DyaK1c7lslCluw%3D%3D (Pubitemid 28164074)
19. J Mendelsohn J Baselga 2000 The EGF receptor family as targets for cancer therapy Oncogene 19 56 6550 6565 10.1038/sj.onc.1204082 11426640 10.1038/sj.onc.1204082 1:CAS:528:DC%2BD3MXhsF2ku7k%3D (Pubitemid 32197693)
20. HJ Aerts L Dubois TM Hackeng R Straathof RK Chiu NG Lieuwes B Jutten SA Weppler G Lammering BG Wouters P Lambin 2007 Development and evaluation of a cetuximab-based imaging probe to target EGFR and EGFRvIII Radiother Oncol 83 3 326 332 10.1016/j.radonc.2007.04.030 17531336 10.1016/j.radonc.2007.04.030 1:CAS:528:DC%2BD2sXmsFKhsb8%3D (Pubitemid 46907977)
21. S Li KR Schmitz PD Jeffrey JJ Wiltzius P Kussie KM Ferguson 2005 Structural basis for inhibition of the epidermal growth factor receptor by cetuximab Cancer Cell 7 4 301 311 10.1016/j.ccr.2005.03.003 15837620 10.1016/j.ccr.2005.03.003 1:CAS:528:DC%2BD2MXjvFSkurk%3D (Pubitemid 40544648)
22. J Harding B Burtness 2005 Cetuximab: an epidermal growth factor receptor chemeric human-murine monoclonal antibody Drugs Today (Barc) 41 2 107 127 10.1358/dot.2005.41.2.882662 10.1358/dot.2005.41.2.882662 1:CAS:528: DC%2BD2MXjtlaitbs%3D (Pubitemid 40461533)
23. B Jutten L Dubois Y Li H Aerts BG Wouters P Lambin J Theys G Lammering 2009 Binding of cetuximab to the EGFRvIII deletion mutant and its biological consequences in malignant glioma cells Radiother Oncol 92 3 393 398 10.1016/j.radonc.2009.06.021 19616334 10.1016/j.radonc.2009.06.021 1:CAS:528:DC%2BD1MXhtFajtL%2FP
24. D Patel A Lahiji S Patel M Franklin X Jimenez DJ Hicklin X Kang 2007 Monoclonal antibody cetuximab binds to and down-regulates constitutively activated epidermal growth factor receptor vIII on the cell surface Anticancer Res 27 5A 3355 3366 17970081 1:CAS:528:DC%2BD2sXhtlSlt7bL (Pubitemid 47607562)
25. J Fukai K Nishio T Itakura F Koizumi 2008 Antitumor activity of cetuximab against malignant glioma cells overexpressing EGFR deletion mutant variant III Cancer Sci 99 10 2062 2069 10.1111/j.1349-7006.2008.00945.x 19016767 1:CAS:528:DC%2BD1cXhsVGltr7O
26. F Kampmeier M Ribbert T Nachreiner S Dembski F Beaufils A Brecht S Barth 2009 Site-specific, covalent labeling of recombinant antibody fragments via fusion to an engineered version of 6-O-alkylguanine DNA alkyltransferase Bioconjug Chem 20 5 1010 1015 10.1021/bc9000257 19388673 10.1021/bc9000257 1:CAS:528:DC%2BD1MXkvFersrs%3D
27. SK Batra S Castelino-Prabhu CJ Wikstrand X Zhu PA Humphrey HS Friedman DD Bigner 1995 Epidermal growth factor ligand-independent, unregulated, cell-transforming potential of a naturally occurring human mutant EGFRvIII gene Cell Growth Differ 6 10 1251 1259 8845302 1:CAS:528:DyaK2MXoslWgs7Y%3D
28. RM Pruss HR Herschman 1977 Variants of 3 T3 cells lacking mitogenic response to epidermal growth factor Proc Natl Acad Sci U S A 74 9 3918 3921 302945 10.1073/pnas.74.9.3918 1:CAS:528:DyaE2sXls1Wqtb8%3D (Pubitemid 8193535)
29. F Kampmeier J Niesen A Koers M Ribbert A Brecht R Fischer F Kiessling S Barth T Thepen 2010 Rapid optical imaging of EGF receptor expression with a single-chain antibody SNAP-tag fusion protein Eur J Nucl Med Mol Imaging 37 10 1926 1934 10.1007/s00259-010-1482-5 20449589 10.1007/s00259-010-1482-5 1:CAS:528:DC%2BC3cXhtFSntrrN
30. J O'Brien I Wilson T Orton F Pognan 2000 Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity Eur J Biochem 267 17 5421 5426 10951200 10.1046/j.1432-1327.2000.01606.x
31. T Kawamoto JD Sato A Le J Polikoff GH Sato J Mendelsohn 1983 Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody Proc Natl Acad Sci U S A 80 5 1337 1341 6298788 10.1073/pnas.80.5.1337 1:CAS:528:DyaL3sXhtlyiu7c%3D (Pubitemid 13082800)
32. MK Nicholas RV Lukas NF Jafri L Faoro R Salgia 2006 Epidermal growth factor receptor - mediated signal transduction in the development and therapy of gliomas Clin Cancer Res 12 24 7261 7270 10.1158/1078-0432.CCR-06-0874 17189397 10.1158/1078-0432.CCR-06-0874 1:CAS:528:DC%2BD28XhtlCrtr7O (Pubitemid 46095397)
33. H Modjtahedi K Affleck C Stubberfield C Dean 1998 EGFR blockade by tyrosine kinase inhibitor or monoclonal antibody inhibits growth, directs terminal differentiation and induces apoptosis in the human squamous cell carcinoma HN5 Int J Oncol 13 2 335 342 9664130 1:CAS:528:DyaK1cXltVKksrc%3D (Pubitemid 28329223)
34. JS de Bono EK Rowinsky 2002 The ErbB receptor family: a therapeutic target for cancer Trends Mol Med 8 4 Suppl S19 S26 11927283 10.1016/S1471- 4914(02)02306-7 (Pubitemid 34297074)
35. D Cunningham Y Humblet S Siena D Khayat H Bleiberg A Santoro D Bets M Mueser A Harstrick C Verslype I Chau E Van Cutsem 2004 Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer N Engl J Med 351 4 337 345 10.1056/NEJMoa033025 15269313 10.1056/NEJMoa033025 1:CAS:528:DC%2BD2cXlvFGitbk%3D (Pubitemid 38944402)
36. J Baselga CL Arteaga 2005 Critical update and emerging trends in epidermal growth factor receptor targeting in cancer J Clin Oncol 23 11 2445 2459 10.1200/JCO.2005.11.890 15753456 10.1200/JCO.2005.11.890 1:CAS:528:DC%2BD2MXjvVykt7c%3D (Pubitemid 47050835)
37. JA Bonner PM Harari J Giralt N Azarnia DM Shin RB Cohen CU Jones R Sur D Raben J Jassem R Ove MS Kies J Baselga H Youssoufian N Amellal EK Rowinsky KK Ang 2006 Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck N Engl J Med 354 6 567 578 10.1056/NEJMoa053422 16467544 10.1056/NEJMoa053422 1:CAS:528:DC%2BD28Xhtleksbs%3D (Pubitemid 43209104)
38. H Zhu X Cao F Ali-Osman S Keir HW Lo 2010 EGFR and EGFRvIII interact with PUMA to inhibit mitochondrial translocalization of PUMA and PUMA-mediated apoptosis independent of EGFR kinase activity Cancer Lett 294 1 101 110 10.1016/j.canlet.2010.01.028 20153921 10.1016/j.canlet.2010.01.028 1:CAS:528:DC%2BC3cXmtlyitLs%3D
39. X Cao H Zhu F Ali-Osman HW Lo 2011 EGFR and EGFRvIII undergo stress- and EGFR kinase inhibitor-induced mitochondrial translocalization: a potential mechanism of EGFR-driven antagonism of apoptosis Mol Cancer 10 26 10.1186/1476-4598-10-26 21388543 10.1186/1476-4598-10-26 1:CAS:528: DC%2BC3MXjslKltrw%3D
40. Y Yao G Wang Z Li B Yan Y Guo X Jiang Z Xi 2010 Mitochondrially localized EGFR is independent of its endocytosis and associates with cell viability Acta Biochim Biophys Sin (Shanghai) 42 11 763 770 10.1093/abbs/gmq090 10.1093/abbs/gmq090 1:CAS:528:DC%2BC3cXhtlKmtLzM
41. AN Cvrljevic D Akhavan M Wu P Martinello FB Furnari AJ Johnston D Guo L Pike WK Cavenee AM Scott PS Mischel NJ Hoogenraad TG Johns 2011 Activation of Src induces mitochondrial localisation of de2-7EGFR (EGFRvIII) in glioma cells: implications for glucose metabolism J Cell Sci 124 Pt 17 2938 2950 10.1242/jcs.083295 21878501 10.1242/jcs.083295 1:CAS:528:DC%2BC3MXhtlCgt7%2FP
42. AW Burgess HS Cho C Eigenbrot KM Ferguson TP Garrett DJ Leahy MA Lemmon MX Sliwkowski CW Ward S Yokoyama 2003 An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors Mol Cell 12 3 541 552 14527402 10.1016/S1097-2765(03)00350-2 1:CAS:528:DC%2BD3sXnvFGrsbc%3D (Pubitemid 37222478)
43. L Frederick G Eley XY Wang CD James 2000 Analysis of genomic rearrangements associated with EGRFvIII expression suggests involvement of Alu repeat elements Neuro Oncol 2 3 159 163 11302336 1:STN:280: DC%2BD3M3jsF2huw%3D%3D
44. L Xue J Lucocq 1998 ERK2 signalling from internalised epidermal growth factor receptor in broken A431 cells Cell Signal 10 5 339 348 9692677 10.1016/S0898-6568(98)00011-4 1:CAS:528:DyaK1cXktVWhuro%3D (Pubitemid 28286790)
45. A Sorkin 2001 Internalization of the epidermal growth factor receptor: role in signalling Biochem Soc Trans 29 Pt 4 480 484 11498013 10.1042/BST0290480 1:CAS:528:DC%2BD3MXms1Slsbk%3D (Pubitemid 32783642)
46. EM Levy G Sycz JM Arriaga MM Barrio EM von Euw SB Morales M Gonzalez J Mordoh M Bianchini 2009 Cetuximab-mediated cellular cytotoxicity is inhibited by HLA-E membrane expression in colon cancer cells Innate Immun 15 2 91 100 10.1177/1753425908101404 19318419 10.1177/1753425908101404 1:CAS:528: DC%2BD1MXlslOrsr8%3D
47. GP Adams LM Weiner 2005 Monoclonal antibody therapy of cancer Nat Biotechnol 23 9 1147 1157 10.1038/nbt1137 16151408 10.1038/nbt1137 1:CAS:528:DC%2BD2MXpvVyrtr0%3D (Pubitemid 41486396)